Equity Profile

AVTR

Avantor, Inc.

Health CareLife Sciences Tools & Services$9.4B

Jul31Fri

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Avantor, Inc. is a global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors....

Key Metrics to Watch

Revenue Growth

Revenue growth is essential to understand how well Avantor is expanding its market presence and meeting customer demand.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help gauge how effectively the company is managing its expenses relative to its earnings.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

AVTR Q2-2026 Earnings Preview

Context

Company Snapshot

Avantor, Inc. is a global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors. Operating in the Health Care sector, Avantor plays a crucial role in supporting research, development, and manufacturing processes, making it significant in the ongoing advancements in health and technology.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+2.25%

Avg Stock Reaction

-9.02%

Last Quarter Recap

In the last quarter (Q1-2026), Avantor reported an EPS of $0.17, slightly beating expectations. However, the stock reacted negatively the following day, indicating investor concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, investors are cautious ahead of the earnings report, given the mixed performance in previous quarters. Analysts are particularly focused on revenue growth and EPS figures to assess the company's trajectory.

Bull Case

If Avantor can demonstrate strong revenue growth and maintain or improve its EPS, it could signal a robust recovery and renewed investor confidence, potentially leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations for revenue growth or EPS, it may reinforce concerns about its ability to navigate market challenges, leading to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for this quarter?

Revenue growth is critical for assessing the company's ability to expand its market share and meet customer needs, which will heavily influence investor sentiment.

How is Avantor managing its gross margins in the current economic environment?

Understanding gross margin management will help investors gauge the company's pricing power and cost control, which are vital for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Avantor's potential for revenue growth due to its strong positioning in the life sciences sector, which is experiencing increased demand.

Supporting Evidence

Options are pricing a 22.75% move, suggesting expectations of volatility that may not align with the company's actual performance capabilities.

Historical data shows a 63% EPS beat rate, indicating that the company has a track record of exceeding expectations.

Recent trends in the life sciences sector suggest a growing demand for Avantor's products and services, which may not be fully reflected in current estimates.

Key Risk

If revenue growth exceeds 10%, it could significantly shift market sentiment and challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on how Avantor is navigating market challenges and whether it can sustain growth in a competitive environment.

Bull Confirmed If

Achieving a revenue growth rate of over 10% year-over-year would confirm the bull case and indicate strong market demand.

Bear Confirmed If

A revenue growth rate below 5% would confirm the bear case, suggesting challenges in maintaining market position.

Pre-Earnings Positioning

Options Market

Implied Move

±22.75%

Historical Avg

±12.1%

Pricing rich

The options market is pricing in a significant move of approximately 22.75%, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±22.8% while AVTR has averaged ±12.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

47.4%

Calls (86K)P/C Ratio: 0.09Puts (388K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Avantor beats expectations, history suggests the stock could see an average one-day move of +3.1%, confirming a positive outlook.

In-Line / Cautious

If results are in line but management offers cautious commentary, the stock may experience muted movement as investors reassess future growth prospects.

Miss

A miss could lead to a significant drop, with history suggesting an average one-day move of -18.42%, reflecting heightened investor concerns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the life sciences sector.
2Insights into customer demand trends and how they are impacting revenue.
3Management's commentary on cost management strategies and their effects on gross margins.
4Details on any new partnerships or collaborations that could enhance market position.
5Guidance on expected performance for the next quarter and beyond.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul28

KNSABMO

Kiniksa Pharmaceuticals International, plc

PreviewView

Jul28

CURBBMO

Company Snapshot

Avantor, Inc. is a global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors....

Key Metrics to Watch

Revenue Growth

Revenue growth is essential to understand how well Avantor is expanding its market presence and meeting customer demand.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help gauge how effectively the company is managing its expenses relative to its earnings.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

AVTR Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+2.25%

Avg Stock Reaction

-9.02%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Avantor can demonstrate strong revenue growth and maintain or improve its EPS, it could signal a robust recovery and renewed investor confidence, potentially leading to a positive stock reaction.

Bear Case

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for this quarter?

Revenue growth is critical for assessing the company's ability to expand its market share and meet customer needs, which will heavily influence investor sentiment.

How is Avantor managing its gross margins in the current economic environment?

Understanding gross margin management will help investors gauge the company's pricing power and cost control, which are vital for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Avantor's potential for revenue growth due to its strong positioning in the life sciences sector, which is experiencing increased demand.

Supporting Evidence

Options are pricing a 22.75% move, suggesting expectations of volatility that may not align with the company's actual performance capabilities.

Historical data shows a 63% EPS beat rate, indicating that the company has a track record of exceeding expectations.

Recent trends in the life sciences sector suggest a growing demand for Avantor's products and services, which may not be fully reflected in current estimates.

Key Risk

If revenue growth exceeds 10%, it could significantly shift market sentiment and challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on how Avantor is navigating market challenges and whether it can sustain growth in a competitive environment.

Bull Confirmed If

Achieving a revenue growth rate of over 10% year-over-year would confirm the bull case and indicate strong market demand.

Bear Confirmed If

A revenue growth rate below 5% would confirm the bear case, suggesting challenges in maintaining market position.

Pre-Earnings Positioning

Options Market

Implied Move

±22.75%

Historical Avg

±12.1%

Pricing rich

The options market is pricing in a significant move of approximately 22.75%, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±22.8% while AVTR has averaged ±12.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

47.4%

Calls (86K)P/C Ratio: 0.09Puts (388K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Avantor beats expectations, history suggests the stock could see an average one-day move of +3.1%, confirming a positive outlook.

In-Line / Cautious

If results are in line but management offers cautious commentary, the stock may experience muted movement as investors reassess future growth prospects.

Miss

A miss could lead to a significant drop, with history suggesting an average one-day move of -18.42%, reflecting heightened investor concerns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the life sciences sector.
2Insights into customer demand trends and how they are impacting revenue.
3Management's commentary on cost management strategies and their effects on gross margins.
4Details on any new partnerships or collaborations that could enhance market position.
5Guidance on expected performance for the next quarter and beyond.